Search Results

The Spectrum of PFO Closure Devices

A closer look at current technology as the indications for PFO closure become clearer.

By Narbeh Melikian, BSc, MB BS, MD, FRCP, and Philip A. MacCarthy, BSc, MB BCh, PhD, FRCP

Manual Thrombus Aspiration in STEMI Treatment

Examining the role of thrombus aspiration as an adjunct to mechanical reperfusion.

By Yalcin Hacioglu, MD; Zubair Ahmed, MD; Abdul Hakeem, MD; and Barry F. Uretsky, MD

Embolic Protection During TAVR: Where Do We Go After PROTECTED TAVR?

Where we stand with data on cerebral embolic protection and a discussion of current and future devices for reducing the burden of stroke during TAVR.

By Amit N. Vora, MD, MPH; Yousif Ahmad, MD, PhD; and Alexandra Lansky, MD

An Interview With Ralph G. Brindis, MD

Dr. Brindis discusses updated guidelines for DAPT, accreditation, the development of a national medical device postmarket surveillance system, and more.

Femoral and Apical Closure Devices for TAVR

Closure devices in various stages of development that may help reduce access-related complications.

By Jonathon White, MD, and Mathew Williams, MD

DCBs for De Novo Lesions and ISR: Why, When, and How

A practical framework for adopting a metal-sparing PCI strategy across established and emerging coronary indications.

By Matteo Sturla, MD; Mauro Gitto, MD; and Pier Pasquale Leone, MD, MSc

Ask the Experts: Is Patent Hemostasis After Radial Access Truly Valuable?

With Ian C. Gilchrist, MD, FSCAI; Kimberly Skelding, MD, FACC, FAHA, FSCAI; and Jennifer A. Tremmel, MD, MS

Interatrial Shunts: A Promising Therapy for HFpEF or Disappointing Mirage?

Highlighting the potential of interatrial shunting in a population with limited therapeutic options.

By Preethi Pirlamarla, MD, and Vikrant Jagadeesan, MD

Point/Counterpoint: Measuring Door-to-Lactate Clearance in Cardiogenic Shock

Two perspectives on whether door-to-lactate clearance is ready to serve as a standardized metric for contemporary cardiogenic shock care.

With Chirag Mehta, MD; Howard A. Cooper, MD; Srihari S. Naidu, MD; and Bernard S. Kadosh, MD

When It Comes to Open-Door Access, Culture Matters

A proper foundation is necessary for access improvement efforts to be successful.

By Joel Sauer, MBA, and Ginger Biesbrock, PA-C, MPH, MPAS, AACC

A Cardiogenic Shock Challenge: Achieving 24-Hour Door-to-Lactate Clearance

SCAI President Srihari S. Naidu, MD, is challenging the interventional cardiology field and all members of the shock team to achieve a door-to-lactate clearance of 24 hours to improve cardiogenic shock outcomes.

With Srihari S. Naidu, MD, MSCAI